Gain Therapeutics, Inc. (GANX): Depreciation & Amortization
$94.0K
Year ended 2025-12-31
$99.5K
Trailing 12 months to 2026-06-30
+13.6%
3-year compound annual growth
+57.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $94.0K | +11.9% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $84.1K | +0.6% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $83.6K | +30.3% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $64.2K | +314.4% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | $15.5K | +61.4% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $9.6K | n/a | 2022-03-25, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $94.0K | +11.9% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $122.0K | -77.9% |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | $90.0K | -28.6% |
| Immunic, Inc. (IMUX) | 2025-12-31 | $168.0K | +25.4% |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $1.0K | -98.4% |
| Phio Pharmaceuticals Corp. (PHIO) | 2025-12-31 | $3.0K | +50.0% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $24.8K | +29.1% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $39.0K | +77.3% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.04M | -12.0% |
Compare GANX, FTH, MBRX, IMUX side by side · Screen every company in Pharmaceutical Preparations ↗